Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,057 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

NCT00005589

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Sydney Cancer Centre at Royal Prince Alfred Hospital Sydney, New South Wales, Australia
  • Westmead Institute for Cancer Research at Westmead Hospital Westmead, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
  • Royal Adelaide Hospital Cancer Centre Adelaide, South Australia, Australia
View all 131 locations
View Trial Details
Completed

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

NCT00048555

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Research site Birmingham, Alabama, United States
  • Research site Tucson, Arizona, United States
  • Research site Los Angeles, California, United States
  • Research site Newport Beach, California, United States
View all 22 locations
View Trial Details
Completed

Malaria Treatment With Injectable ArteSunate

NCT01828333

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations
  • Centre de Santé CECO Kimpese, Bas-Congo Province, Democratic Republic of the Congo
  • Centre de Santé la Famille Kimpese, Bas-Congo Province, Democratic Republic of the Congo
  • Hôpital Général de Référence IME Kimpese, Bas-Congo Province, Democratic Republic of the Congo
  • Centre de Santé Ngeba Kisantu, Bas-Congo Province, Democratic Republic of the Congo
View Trial Details
Completed

Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia

NCT00462332

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Universita Degli Studi di Bari Bari, Italy
  • Universita Cattolica del Sacro Cuore - Campobasso Campobasso, Italy
  • Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy
View all 23 locations
View Trial Details

Related conditions